Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > I bought 10 thousand at 425
View:
Post by Zxcvbnmlkjhgfds on May 10, 2017 11:03pm

I bought 10 thousand at 425

Are you serious I bought 10 thousand what should I do please I need advise
Comment by TheLizardKing on May 11, 2017 12:50am
Relax, and don't panic. Think back to why you bought this company over another. All of those things are still true. It's just that fear news sells. Last month it was pesticides and this month it's supply. You can either gamble and short, sell on fear, accumulate on these lessor shares or hold long, on the companies you've researched and bought. Sometimes the best thing to do, is to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities